About Red Leaf Medical

Welcome to Red Leaf Medical, a provider of leading edge medical solutions to hospitals and patients. Red Leaf Medical has built a track record of successfully establishing innovative medical products in the Canadian healthcare system. Whether you are a patient looking for more information on specific product or a company exploring possible business opportunities, we thank you for visiting our website.

Introducing a NEW Hyaluronic Acid for the treatment of IC/BPS and Radiation/Chemo/BCG induced hemorrhagic Cystitis

By |2020-09-24T15:38:30-04:00September 24th, 2020|news|

Mississauga, Canada (September 2020) Red Leaf Medical Inc. is delighted to announce the Canadian launch of INSTYLAN™, a new brand of Hyaluronic Acid (HA) for bladder instillation. INSTYLAN™ is indicated to treat Interstitial Cystitis (IC)/Bladder Pain Syndrome (BPS). Typical symptoms of IC/BPS include pelvic pain, frequency, nocturia, and urgency to urinate. Approximately 330,000 to [...]

Red Leaf Medical profiled in PharmaBoardroom

By |2018-05-16T14:15:38-04:00March 27th, 2018|news|

Red Leaf Medical, founded in 2009, is unique in its approach to the Canadian healthcare market, being the only company focused exclusively on urology solutions. Charles Ko, managing director, discusses Red Leaf Medical's foundation, the significance of listening to customers' needs and how a sound domestic reputation can lead to expansive international partnerships.

PROfortil™ Clinically Proven Treatment for Male Infertility Now available in Canada

By |2018-05-16T14:14:46-04:00January 4th, 2018|news|

Mississauga, Canada (January, 2018)  Red Leaf Medical Inc. is pleased to announce the Canadian launch of PROfortil™*, a clinically proven treatment for male fertility disorders that contains a patented composition of micronutrients. According to the Government of Canada Report on Fertility, approximately 16%, or one in six couples, experience infertility and the male is [...]

Red Leaf Medical Enters the Urinary Tract Infection Market Secures exclusive rights to market UROMUNE® in Canada

By |2017-10-19T12:31:35-04:00October 19th, 2017|news|

Mississauga, Canada (October 18, 2017) Red Leaf Medical Inc. is pleased to announce that it has signed an exclusive Canadian distribution agreement with Inmunotek, a leading pharmaceutical company based in Spain, to commercialize UROMUNE®, a novel sublingual vaccine for the treatment of recurrent urinary tract infection. Urinary tract infections (UTIs) are one of the most [...]

Red Leaf Medical Ranks No. 233 on the 2017 PROFIT 500

By |2017-09-14T13:11:51-04:00September 14th, 2017|news|

Canadian Business unveils 29th annual list of Canada’s Fastest-Growing Companies Red Leaf Medical Ranks in the PROFIT 500 for Third Year in a Row Mississauga, Ontario (September 14, 2017) Canadian Business and PROFIT today ranked Red Leaf Medical Inc. on the 29th annual PROFIT 500, the definitive ranking of Canada’s Fastest-Growing Companies. The ranking is [...]

Red Leaf Medical introduces Magnetic Black-Star to the Canadian Market

By |2017-03-28T13:35:00-04:00March 28th, 2017|news|

Innovative Technology Improves Patient Care Mississauga, Canada (March 14, 2017) Red Leaf Medical Inc. is pleased to announce Health Canada’s approval of Magnetic Black-Star, a novel Double-J (DJ) ureteric stent system. The addition of this innovative product to Red Leaf Medical’s portfolio further strengthens the company’s extensive offering of premium quality medical products and solutions [...]

Go to Top